Method for endoscopic hemostasis of variceal hemorrhages in liver cirrhosis

Anghelici Gheorghe; Panici Ion; Pisarenco Sergiu; Crudu Oleg; Zugrav Tatiana; Lupu Gheorghe

Articolul precedent

Articolul urmator

134

SM ISO690:2012

ANGHELICI, Gheorghe, PANICI, Ion, PISARENCO, Sergiu, CRUDU, Oleg, ZUGRAV, Tatiana, LUPU, Gheorghe. Method for endoscopic hemostasis of variceal hemorrhages in liver cirrhosis. In: Exhibition of Inventics “Inventica 2020”, 29-31 iulie 2020, Iași. Iași: Technical University “Gheorghe Asachi” of Iași, 2020, Ediția a 24-a, p. 358. ISSN 1844-7880.

EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core

Exhibition of Inventics “Inventica 2020”
Ediția a 24-a, 2020

Simpozionul "Exhibition of Inventics “Inventica 2020”"
Iași, Romania, 29-31 iulie 2020

Method for endoscopic hemostasis of variceal hemorrhages in liver cirrhosis

Pag. 358-358

Anghelici Gheorghe, Panici Ion, Pisarenco Sergiu, Crudu Oleg, Zugrav Tatiana, Lupu Gheorghe

”Nicolae Testemițanu” State University of Medicine and Pharmacy

Disponibil în IBN: 23 februarie 2024

Descarcă PDF

Teza

Invenţia se referă la medicină, în special la hemostaza endoscopică a hemoragiilor din variceesofago-gastrice în caz de ciroză hepatică. Esenţa invenţiei constă în aceea că endoscopic se injectează în lumenul varicelui o soluţie de ceftriaxon 0,5-1,0 g, dizolvat în 5,0-10,0 ml solutie de lidocaină de 2%, apoi se introduc concomitent componentele unui adeziv fibrinic, şi anume primul component include o soluţie de fibrinogen, iar al doilea component include un amestec de soluţii de aprotinină, trombinășiclorură de Ca+2, înurmătorulraport al componentelor la 1 ml: fibrinogen (mg) 15...30 aprotinină (KIU) 250...1000 trombină (IU) 25...100 clorurăde Ca+2(μmol) 15...30. The invention relates to medicine, in particular to endoscopic hemostasis of hemorrhages from esophageal-gastric varices in liver cirrhosis. Summary of the invention consists in that is endoscopically injected into the varix lumen 0.51.0 g of a ceftriaxone solution, dis-solved in 5.010.0 ml of a 2% lidocaine so-lution, then are simultaneously introduced the components of a fibrin adhesive, namely the first component includes a fibrinogen so-lution, and the second component includes a mixture of aprotinin, thrombin and calcium chloride solutions, in the following ratio of components in 1 ml: fibrinogen (mg) 1530 aprotinin (KIU) 2501000 thrombin (IU) 25100 calcium chloride (μmol) 1530.

Cerif XML Export

<?xml version='1.0' encoding='utf-8'?>
<CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'>
<cfResPubl>
<cfResPublId>ibn-ResPubl-198125</cfResPublId>
<cfResPublDate>2020</cfResPublDate>
<cfVol>Ediția a 24-a</cfVol>
<cfStartPage>358</cfStartPage>
<cfISBN></cfISBN>
<cfURI>https://ibn.idsi.md/ro/vizualizare_articol/198125</cfURI>
<cfTitle cfLangCode='EN' cfTrans='o'>Method for endoscopic hemostasis of variceal hemorrhages in liver cirrhosis</cfTitle>
<cfResPubl_Class>
<cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId>
<cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId>
<cfStartDate>2020T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfResPubl_Class>
<cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId>
<cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId>
<cfStartDate>2020T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfPers_ResPubl>
<cfPersId>ibn-person-11667</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2020T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-16168</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2020T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-13460</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2020T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-11017</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2020T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-54573</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2020T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-43697</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2020T24:00:00</cfStartDate>
</cfPers_ResPubl>
</cfResPubl>
<cfPers>
<cfPersId>ibn-Pers-11667</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-11667-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2020T24:00:00</cfStartDate>
<cfFamilyNames>Ангелич</cfFamilyNames>
<cfFirstNames>Георгий</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-16168</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-16168-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2020T24:00:00</cfStartDate>
<cfFamilyNames>Panici</cfFamilyNames>
<cfFirstNames>Ion</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-13460</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-13460-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2020T24:00:00</cfStartDate>
<cfFamilyNames>Pisarenco</cfFamilyNames>
<cfFirstNames>Sergiu</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-11017</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-11017-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2020T24:00:00</cfStartDate>
<cfFamilyNames>Crudu</cfFamilyNames>
<cfFirstNames>Oleg</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-54573</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-54573-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2020T24:00:00</cfStartDate>
<cfFamilyNames>Zugrav</cfFamilyNames>
<cfFirstNames>Tatiana</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-43697</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-43697-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2020T24:00:00</cfStartDate>
<cfFamilyNames>Lupu</cfFamilyNames>
<cfFirstNames>Gheorghe</cfFirstNames>
</cfPersName_Pers>
</cfPers>
</CERIF>